Cytomegalovirus (CMV) Vaccines Market Key Players, Supply Chain and Analysis, Application, Market Drivers, Restraints, in-Depth Analysis, Forecast to 2030

Cytomegalovirus (CMV) also known as HCMV, or Human Herpesvirus 5 (HHV-5) is the virus most commonly transmitted to a developing fetus. It is a common virus that infects people of all ages. According to the CDC, over half of adults by age 40 have been infected with CMV. Most people infected with CMV show no signs or symptoms. Whereas when a baby is born with cytomegalovirus (CMV) infection, it is called congenital CMV. Each year, approximately 5,000 infants in the U.S. may develop permanent problems due to CMV, some of the severe problems, includes deafness, blindness, and mental retardation. Furthermore, the global prevalence of congenital cytomegalovirus is said to be 0.3 - 2.0%. The Institute of Medicine (IOM) of the National Academy of Sciences, has designated CMV as a "highest priority" category for vaccine development, citing the years of life and disability that could be saved.

Increasing incidences & prevalence of CMV and rising investments towards the development of Cytomegalovirus (CMV) vaccines by numerous, major & small companies, coupled with the large number of pipeline products can be attributed to the growing demand for global cytomegalovirus (CMV) vaccines market in the coming years.

Major Key Players of the Cytomegalovirus (CMV) Vaccines Market are:Merck's, AlphaVax, Inc., and Moderna, Inc. are some companies working on CMV immunizations.

Read More @ https://www.openpr.com/news/2018552/cytomegalovirus-cmv-vaccines-market-key-players-supply